Asia Pacific Oligonucleotide Synthesis Market Size, Share, and Analysis by 2027

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027

Asia Pacific Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users), and Country

  • Report Date : Oct 2019
  • Report Code : TIPRE00007129
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 159

The Asia Pacific oligonucleotide synthesis market is expected to reach US$ 872.98 Mn in 2027 from US$ 334.26 Mn in 2018 the market is estimated to grow with a CAGR of 14.7% from 2019-2027.

The growth of the Oligonucleotide Synthesis market is driven by the factors such as, the growing use of synthesized oligonucleotides and government support for biotechnology research in Asia Pacific. However, the market is likely to slower down its growth due to dearth of skilled professional in the region.

The high growth of the market is anticipated on account of the rise in the investment are enabling technological developments and standard biological parts. For Instance, The Biotechnology Industry Research Assistance Council (BIRAC) is a public entity developed by the DBT, government of India, which aims to strengthen and empower the emerging biotech enterprises. DBT along with the BIRAC plays important role in transforming the biotech sector by Make in India and Startup India and the aim is to inform the India Bioeconomy to US$ 100 billion by the 2025. Developments such as partnerships and increasing focus on synthetic biology research is expected to contribute to the growth of the market.

Japan is expected to lead the market in the Asia Pacific region owing to the rising prevalence of chronic diseases such as coronary diseases & cancer and increase in awareness regarding cancer in the country. Moreover the government initiative for research activities, collaboration among major player in country. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

Rest of Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

TIPRE00007129-img1
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION

By Product

  • Synthesized Oligonucleotides
    • Primers
    • Probes
    • Large-Scale Synthesis
    • Others
  • Reagents
  • Equipment

By Application

  • Research
  • Diagnostics
  • Therapeutics

By End User

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Other End Users

By Geography

  • Asia Pacific

    • China
    • Japan
    • India
    • Australia
    • South Korea

Company Profiles

  • Molecular Assemblies
  • Twist Bioscience
  • Evonetix
  • Nuclera Nucleics Ltd
  • Camena Bio
  • DNA Script
  • Iridia, Inc.,
  • Helixworks
  • Ansa Biotechnologies, Inc.,
  • Synthomics, Inc.,

Asia Pacific Oligonucleotide Synthesis Report Scope

Report Attribute Details
Market size in 2018 US$ 334.26 Million
Market Size by 2027 US$ 872.98 Million
Global CAGR (2019 - 2027) 14.7%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Product
  • Synthesized Oligonucleotides
  • Reagents
  • Equipment
By Application
  • Research
  • Diagnostics
  • Therapeutics
By End User
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Other End Users
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Molecular Assemblies
  • Twist Bioscience
  • Evonetix
  • Nuclera Nucleics Ltd
  • Camena Bio
  • DNA Script
  • Iridia, Inc.,
  • Helixworks
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies

     

    1. Molecular Assemblies
    2. Twist Bioscience
    3. Evonetix
    4. Nuclera Nucleics Ltd
    5. Camena Bio
    6. DNA Script
    7. Iridia, Inc.,
    8. Helixworks
    9. Ansa Biotechnologies, Inc.,
    10. Synthomics, Inc.,
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo